UPC

Universe Pharmaceuticals Inc. Class A Ordinary Shares

UPC
Closed
$5.20
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
Country

CN

CEO

Mr. Gang Lai

IPO date

2021

Employees

225

ISIN

KYG9442G1385

Key stats

Open

$5.24

Volume

43.33K

Market cap

$3.66M

Prev. close

$5.34

Impl / hst vl

-

Open interest

$0.00

$4.57

Day’s Range

$6.82

$2.00

52W Range

$17.96

Valuation

50
Valuation score
Fairly Valued
P/E
-
P/S
0.21
P/B
0.07
Current ratio
4.07
Debt / Equity
-0.43
ROE
-6.60%
Gross margin
36.03%
Income growth
-88.21%
FCF growth
-84.40

Analysts estimates

Earnings

Q3 ‘25 revenue
$8.71M
Q3 ‘25 net income
-$387.30K
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply